An interventional study of TFNA extended-short nail (235 mm) and TFNA long nail (260-480mm) in Hip Fractures, sponsored by Vestre Viken Hospital Trust. Recruiting at 2 sites in Norway. Per ClinicalTrials.gov, last updated 2024-05-29.
Sponsored by Vestre Viken Hospital Trust · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 30 studies in Hip Fractures with a site in Norway — 4 open to participants now, 6 under way, none of them phase 3. Hip Fractures · Norway.
Among the 30 studies in Hip Fractures with a site in Norway, this one is the 4th largest by planned enrollment of the 25 interventional ones that give a count, is one of 2 that started in 2020, is one of 20 with no phase, and was the 24th registered.
843 studies on the registry are indexed under Hip Fractures; 166 are open to participants now.
Browse Hip Fractures studies →4 of the 30 studies in Hip Fractures with a site in Norway are open now. Recruiting first, the newest first:
University of Southern California · Sites in Norway, United States, Canada and 2 more countries
Ages 60+
University Hospital, Akershus · Sites in Norway
Ages 75+
Helse Stavanger HF · Sites in Norway
Ages 65–120
A study can be open while its sites in Norway have not opened yet or have stopped. Only those recruiting at a site in Norway →
Of the 104 Hip Fractures studies recruiting now, 82 (79%) set no upper age limit and 6 (6%) stop at 75 or younger; 12 take children under 18; 9 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
30 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 2 started in 2020.
This study's planned enrollment of 800 is above the median of 86 across 534 interventional studies indexed under Hip Fractures.
Median enrollment 200 across the 25 interventional studies, 184 across the 5 observational. Of the 23 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 30 have an industry lead sponsor. The 10 most frequent:
Vestre Viken Hospital Trust is the lead sponsor of 52 studies on the registry; 23 are open to participants now.
Vestre Viken Hospital Trust has 3 studies filed under Hip Fractures — fewer than ten, so there is no comparison to draw.
1 of the studies in Hip Fractures with a site in Norway that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04868305Helse Stavanger HFIntramedullary Nail Versus Hip Arthroplasty in Unstable Trochanteric Hip Fractures | 2027-03-31 |
Add it to your calendar (.ics) → With an account.
Among the 30 studies in Hip Fractures with a site in Norway, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Fractures of the upper part of the femur may be treated with intramedullary nails. There are different designs to choose from. The intention of this RCT is to compare two nails with some of the same properties, but with different lengths. Usually, it is the surgeon who decides which nail to be used. The literature indicates that there is a lack of good evidence in the decision-making, and that the choice often depends on personal preferences and experience of the surgeon. Therefore, the investigators want to compare whether one of the nails has a better outcome than the other, and in that way be able to give some clearer guidelines for treatment. Patients will be randomized into two groups, one receiving a long nail and one receiving an extended-short nail and compare surgical and functional outcomes. Information from the operation and subsequent check-ups will be analysed. The hypothesis is that the extended-short nail can reduce operating time, bleeding, fluoroscopy time and give equal or better functional outcome, without increasing reoperation rates or mortality.
Background Intramedullary nails have in recent years become the preferred technique compared to DHS when treating proximal femur fractures. A Norwegian RCT has showed the same frequency of postoperative pain, functional outcome and rate of reoperations comparing the two techniques. Nails are usually provided in a long and short model. Deciding which nail length to use is highly discussed, and often a long nail is preferred, because it gives a theoretically more stable and secure fixation of the femur. There are, however many advantages of using a short nail. It is less time consuming as there is no need for reaming, securing the long nail distally requires more fluoroscopy time, and distal locking of the long nail has also been shown to increase the risk of perioperative fractures. Perioperative bleeding and postoperative blood transfusions are reduced when using a short nail, and a long nail may also give more pain distally around the thigh and around the knee owing to cortical impingement. Finally, the long nail is more expensive compared to short models. There is a perception in the orthopedic society that there's a higher risk of periprosthetic fractures with short nails, but the latest generations of nails have improved this problem. Most studies report no difference in periprostetic fractures between long and short nails. Recently, new extended-short versions of medullary nails are being produced. The extended-short nail combines the mechanical properties seen in a long nail and the surgical simplicity of a short nail. This new nail type may replace the use of several long nails being placed just to be on the safe side, and thus reduce operating time, bleeding and postoperative pain associated with a long nail. Biomechanical studies have showed that the mechanical properties of long and extended-short nails are predominantly comparable, but to our knowledge no clinical studies comparing the extended-short and long nails have been performed to date. The advantages of an extended-short nail are potentially great, which makes it important to clarify which opportunities there are to benefit from this type of nail for certain types of fractures, both in the interest of the patient as well as the economic healthcare perspective.
Purpose In a well-defined population of patients with proximal femur fractures within a certain anatomical area the aim is to compare the extended-short nail with the long nail, to evaluate differences in functional and surgical outcome.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Implantation of TFNA extended-short nail (235 mm)
Device: TFNA extended-short nail (235 mm)
Implantation of TFNA long nail (260-480 mm)
Device: TFNA long nail (260-480mm)
The extended short version of the TFN-advanced proximal femoral nailing system (TFNA)
Also known as: TFN-advanced proximal femoral nailing system (TFNA) 235 mm
The long version of the TFN-advanced proximal femoral nailing system (TFNA)
Also known as: TFN-advanced proximal femoral nailing system (TFNA) 260-480mm
Difference in Short Physical Performance Battery (SPPB)-score
Short Physical Performance Battery (SPPB)-score, ranges from 0-12, 12 is the best indicating a good physical function.
Time frame: At 3 months and 1 year
Difference in Operation time
Operation time in minutes
Time frame: Surgery date
Difference in Blood loss
Blood loss during surgery
Time frame: Surgery date
Difference in Harris Hip score
Harris Hip score, ranges from 0-100, 100 is the best score, a high score indicates good physical function.
Time frame: 3 months and 1 year
Difference in EQ5D-5L (EuroQoL 5L - health-related quality of life)
EQ5D-5L (EuroQoL 5L - health-related quality of life)measures health status terms of five dimensions (5D); mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Mobility dimension asks about the person's walking ability. Self-care dimension asks about the ability to wash or dress by oneself, and usual activities dimension measures performance in "work, study, housework, family or leisure activities". In pain/discomfort dimension, it asks how much pain or discomfort they have, and in anxiety/depression dimension, it asks how anxious or depressed they are. The respondents self-rate their level of severity for each dimension using three-level (EQ-5D-3L) or five-level (EQ-5D-5L) scale
Time frame: 3 months and 1 year
Difference in Transfusion after surgery
Need for transfusion of blood products after surgery
Time frame: 2 weeks after surgery
Difference in Fluoroscopy time
Fluoroscopy time during surgery
Time frame: Surgery date
Difference in Postoperative complications
Any postoperative complications
Time frame: Minimally 1 year
Difference in Mortality
Mortality after surgery
Time frame: Minimally 1 year
Difference in Reoperations
Reoperations of any kind
Time frame: Minimally 1 year
Plan to share: No
No publications or documents are linked to this record.
Started Dec 2020 (actual). Primary completion is estimated for Nov 2024, 47 months after the start.
Of 221 non-industry interventional studies with no phase under Hip Fractures, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 55. This study's planned 47 months is above that.
Counting every sponsor, half of 237 studies reached it within 29 months; a quarter within 10 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Vestre Viken Hospital Trust